Open original FDA record ↗Recall record
- FDA identifier
- Z-2327-2025
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Aug 20, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Source facts
- Action
- On July 24, 2025, firm notified physicians via Important Medical Device Information letters. The letter provides information on the management of gradually rising daily subthreshold, low-voltage shock impedance (LVSI) pattern associated with calcification of expanded polytetrafluoroethylene (ePTFE) coated single coil (SC) and dual coil (DC) RELIANCE defibrillation leads manufactured by Boston Scientific Corporation between 2002 to 2021. Letter includes recommendations for routine follow-ups of affected leads, and considerations to take if lead replacement is planned. The firm is not recommending any changes to the scheduled follow-up interval for patients with ePTFE lead models.
- Initiated
- 2025-07-24
- Root cause
- Component design/selection
- Distribution
- Worldwide Distribution. US nationwide. International distribution worldwide.
- Recall number
- Z-2327-2025
- Recall status
- Open, Classified
- CDRH record ID
- 215220
- FDA classified
- 2025-08-20
- Recall event number
- 97318